This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marek, J. Articles by Kasirajan, K. Search for Related Content PubMed PubMed Citation Articles by Marek, J. Articles by Kasirajan, K. Social Bookmarking                         What's this?

Endoluminal Graft Repair of Abdominal Aortic Aneurysms by Vascular Surgeons at a Nonclinical Trial Center

University of New Mexico School of Medicine, Division of Vascular Surgery, 2ACC, 915 Camino de Salud NE, Albuquerque, NM 87131-5341 jmarek{at}salud.unm.edu

M. Langsfeld, MD

R. B. Dickinson, MD

M. J. Tullis, MD

K. Kasirajan, MD

Division of Vascular Surgery, University of New Mexico School of Medicine, Albuquerque, NM

The purpose of this study was to compare the early results and complication rates of commercially available endoluminal grafts (ELG) for abdominal aortic aneurysm (AAA) by a team of vascular surgeons at a nontrial center with those of published results from trial centers. A retrospective chart review of all patients undergoing endoluminal graft repair of AAA was made at the medical center. From October 1, 1999, to December 31, 2000, a team of vascular surgeons electively repaired AAAs in 100 patients at a regional referral center. Of these patients, 49 underwent repair with a commercially available ELG (35 AneuRx, 14 Ancure) whereas the remaining were repaired with an open operation. In the ELG group, the primary technical success rate was 100% with a 30-day mortality rate of 2.0%. The average hospital length of stay was 3.28 days with ICU stay of 1.20 days. The average operative estimated blood loss was 501 mL (100-2,500) with average transfusions of 0.49 unit packed red blood cells (prbc) (0-6). Eighty-eight percent of ELG patients left the hospital without complication.Seven patients (14%) required 1 1 follow-up procedures for complications including endoleak, limb or graft thrombosis, graft stenosis, distal embolization, or wound complications. Three of 26 patients (1 1%) with 6-month computed tomography follow-up had evidence of endoleak (2 have subsequently undergone lumbar embolization). Only 1 6-month follow-up patient had shown increased aneurysm size before endoleak treatment. A team of board-certified vascular surgeons at a nonclinical trial center can safely perform ELG for AAA with results similar to those of published series from trial centers.

Vascular and Endovascular Surgery, Vol. 36, No. 2, 97-104 (2002)
DOI: 10.1177/153857440203600204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?